美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Opexa Therapeutics Inc. Warrants

0.0876

-0.0022-2.45%

成交量：316.75萬

成交額：27.75萬

市值：- -

市盈率：- -

高：0.1035

開：0.1005

低：0.0800

收：0.0898

52周最高：0.3360

52周最低：0.0053

股本：- -

流通股本：- -

量比：- -

換手率：- -

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Opexa Therapeutics Inc. Warrants

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Opexa Therapeutics is a biopharmaceutical company developing autologous cellular therapies to treat several major illnesses, including multiple sclerosis, rheumatoid arthritis, diabetes, and cardiovascular disease.

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/OPXAW/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"OPXAW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OPXAW\",,,,,undefined,":{"symbol":"OPXAW","market":"US","secType":"STK","nameCN":"Opexa Therapeutics Inc. Warrants","latestPrice":0.0876,"timestamp":1505937600000,"preClose":0.0898,"halted":0,"volume":3167481,"delay":0,"changeRate":-0.02449888641425398,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-0.0022,"latestTime":"09-20 16:00:00 EDT","open":0.1005,"high":0.1035,"low":0.08,"amount":277471.3356,"amplitude":0.261693,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.0898,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OPXAW\",,,,,undefined,":{"symbol":"OPXAW","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0.1035,"amplitude":0.261693,"preClose":0.0898,"low":0.08,"week52Low":0.0053,"pbRate":"--","week52High":0.336,"institutionHeld":0,"latestPrice":0.0876,"eps":0,"divideRate":0,"volume":3167481,"delay":0,"open":0.1005,"prevYearClose":0.9071},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OPXAW\",params:#limit:5,,,undefined,":[{"date":"2017-09-21","symbol":"OPXAW","type":"split","dateTimestamp":1505966400000,"forFactor":10.355527,"toFactor":1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OPXAW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OPXAW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://","stockEarnings":[{"period":"1week","weight":-0.9034},{"period":"1month","weight":-0.9034},{"period":"3month","weight":-0.9034},{"period":"6month","weight":-0.9034},{"period":"1year","weight":-0.9034},{"period":"ytd","weight":-0.9034}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Opexa Therapeutics is a biopharmaceutical company developing autologous cellular therapies to treat several major illnesses, including multiple sclerosis, rheumatoid arthritis, diabetes, and cardiovascular disease.","exchange":"NASDAQ","name":"Opexa Therapeutics Inc. Warrants","nameEN":"Opexa Therapeutics, Inc. Warrants"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"OPXAW\",market:\"US\",,,undefined,":null}}